Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

An Update from Myelo: Expanding Our Team and Evaluating Data

Posted on December 14th, 2016 by in Pharma R&D

The focus of our current non-clinical research at Myelo Therapeutics is to fully elucidate the mode of action for prevention of myelosuppression as well as Myelo001โ€™s antiviral capabilities. But to achieve this goal, itโ€™s important to have highly skilled and motivated personnel within your team. Continue reading “An Update from Myelo: Expanding Our Team and Evaluating Data” »

Elsevier and Illumina: A meeting of mind and spirit

Posted on August 22nd, 2016 by in Pharma R&D

One of the strongest arguments for using the molecular biology modeling tool Pathway Studio is the rich content underlying its knowledge database. This was driven home recently in a conversation with the DNA/RNA sequencing company Illumina. Continue reading “Elsevier and Illumina: A meeting of mind and spirit” »

Where and How to Find Co-Occurrences in Disease Biology Research

Posted on July 29th, 2016 by in Chemistry

In research, a co-occurrence refers to two linked concepts appearing within one sentence. In disease biology, a good example would be a sentence with facts that link a protein to a disease, biological functions or other proteins. Continue reading “Where and How to Find Co-Occurrences in Disease Biology Research” »